Detailed program of oral communications and poster

Detailed program of oral communications and poster sessions
Longdagen 23-24 April, 2014
Oral Communications – Basic Science O1
Thursday April 24, 13:00-14:30
Chairs:
Irene Heijink, Groningen
Mirjam Kool, Rotterdam
O1.1 Insufficient read-through correction of premature termination codons by PTC124 and G418 in
human cystic fibrosis organoids.
D.D. van Ommen, L.A.W. Vijftigschild, H.M. Janssens, K.M. de Winter-de Groot, C.K. van der Ent, J.M.
Beekman. Utrecht, Rotterdam, The Netherlands
O1.2 Hyperactivity of the IL33-ST2 axis during postnatal alveolarization increases susceptibility to
house dust mite sensitization via skewing of CD11b+ dendritic cells.
I.M. de Kleer, M. Willart, M. Plantinga, M. Kool, H. Hammad, R. Hendriks, B. Lambrecht. Ghent, Belgium,
Rotterdam, Utrecht, The Netherlands
O1.3 A lysate of Helicobacter pylori induces IL-10 secretion by human monocyte-derived dendritic
cells and primes for IL-10 producing T cells.
Yolanda van Wijck, Alwin J. van der Ham, Leonie Hussaarts, Maria Yazdanbakhs2, Pieter S. Hiemstra, Anne
Müller, Hermelijn H. Smits, Christian Taube.. Leiden, The Netherlands, Zürich, Switzerland
O1.4 The RANK/RANKL/OPG-axis in pulmonary fibrosis: which cell types are involved?
CE Boorsma, C Draijer, RH Cool, CA Brandsma, G Nossent, D Brass, W Timens, BN Melgert. Groningen, The
Netherlands, Durham, NC, USA
O1.5 Muscarinic M3 receptors on structural cells regulate neutrophilic inflammation in mice
LEM Kistemaker, R van Os, A Ausema, IST Bos, MN Hylkema, PS Hiemstra, J Wess, H Meurs, HAM Kerstjens,
R Gosens. Groningen, Leiden, The Netherlands, Bethesda, USA
O1.6 Acetate is more effective than a glucocorticoid steroid at preventing and reducing neutrophilic
airway inflammation in a cigarette smoke induced mouse model for COPD
Gillina F.G. Bezemer, Ingrid van Ark, Amy Marijne, A. Thea Leusink-Muis, Aletta D. Kraneveld, Johan
Garssen, Gert Folkerts. Utrecht, The Netherlands
Oral Communications – Clinical Science O2
Thursday April 24, 13:00-14:30
Chairs:
Kors van de Ent, Utrecht
Thys van der Molen, Groningen
1
O2.1 Accelerated ageing in the ICE-Age study: Individualized COPD evaluation in relation to Ageing.
Poornima Gopal, Niki L. Reynaert, Frits M.E. Franssen, Geja Hageman, Emiel F.M. Wouters, Erica P.A.
Rutten. Maastricht, Horn, the Netherlands
O2.2
Exacerbation of moderate asthma during inhaled steroid withdrawal does not induce systemic
activation of coagulation
M.M.S. Sneeboer, M.A. van de Pol, N. Fens1, C.J. Majoor, J.C. Meijers, P.W. Kamphuisen, R. Lutter, P.J.
Sterk, E.H.D. Bel. Amsterdam, Groningen, The Netherlands
O2.3 SOLUBLE CD59 IS A NOVEL BIOMARKER FOR THE PREDICTION OF THE BRONCHIOLITIS
OBLITERANS SYNDROME
K. Budding, E.A. van de Graaf, T. Hoefnagel, C.E. Hack, H.G. Otten. Utrecht, The Netherlands
O2.4
Differential macrophage subsets in males and females with asthma
Christina Draijer, Patricia Robbe, Carian E. Boorsma, Machteld N. Hylkema, Wim Timens, Dirkje S. Postma,
Nick H.T. ten Hacken, Barbro N. Melgert. Groningen, The Netherlands
O2.5 Increased Bruton tyrosine kinase (BTK) -protein expression in B cells in patients with pulmonary
arterial hypertension.
P. Heukels, L.P. Kil, J.A.C. van Hulst, M.J. W. de Bruijn, M. van Nimwegen, L.M. van den Toorn, K.A.T.
Boomars, J.W. Roos-Hesselink, H.C. Hoogsteden, R.W. Hendriks, B. van den Blink, M. Kool. Rotterdam,
The Netherlands
O2.6
Tumor microenvironmental studies indicate controlled trafficking and preferential homing of
immune cells towards the tumor
L.A. Lievense, R. Cornelissen, K. Bezemer, M.E.H. Kaijen, R.W. Hendriks, J.G.J.V. Aerts, J.P.J.J. Hegmans
Rotterdam, The Netherlands
Poster presentations Wednesday April 23, 15:00-16:00
Poster Session P1: Basic Science
Chairs:
Leo Koenderman, Utrecht
Barbro Melgert, Groningen
P1.1
The isolation of culturable micro-organisms from tobacco, cigarette smoke and second hand
cigarette smoke: implications for COPD
Gillina F.G. Bezemer, Éric Jubinville, Aniek Dijkshoorn, Frank Stassen, Petra Wolffs, Nathalie Turgeon,
Marc Veillette, Catherine Viel, Marie-Eve Dubois, Steve Labrie, Johan Garssen, Caroline Duchaine, Gert
Folkerts. Utrecht, Maastricht, The Netherlands, Ste-Foy Québec, Canada;
P1.2
Crosstalk between epithelium and fibroblasts; implications for COPD
Emmanuel T. Osei, Corry-Anke Brandsma, Jacobien A. Noordhoek, Wim Timens, Dirkje Postma, Irene
Heijink. Groningen, The Netherlands
P1.3 TELOMERE LENGTH OF PERIPHERAL BLOOD MONOCYTES IN INTERSTITIAL LUNG DISEASES
R. Snetselaar, C.H.M. van Moorsel, K.M. Kazemier, J.J. van der Vis, J.C. Grutters. Nieuwegein, Utrecht,
the Netherlands
P1.4 Polymorphisms of SLCO1B1 transporter and CYP enzymes are not associated with development of
idiopathic interstitial pneumonia in statin users
HA Crommelin, VHM Deneer, E Schelhaas, CHM van Moorsel, JC Grutters.. Nieuwegein, The Netherlands;
P1.5 Mesenchymal stromal cells reduce acute LPS-induced pulmonary and systemic inflammation
P.Padmini.S.J.Khedoe, Sander Kooijman, Merete Long, Melissa van Pel, Patrick C.N. Rensen, Jimmy F.P.
Berbée, Pieter S. Hiemstra. Eindhoven, Leiden, The Netherlands
2
P1.6 Leptin-induced Neutrophil Migration In Acute Lung Injury: An Important Role For Alternate
Signaling Pathways
N.D. Ubags, E. Burg, C. M. Hayes, M.E. Poynter, E.F. Wouters, J.H. Vernooy, B.T. Suratt. Maastricht, The
Netherlands; Vermont, Burlington, VT, USA
P1.7 Internalization of silica in bronchial epithelial cells
K.J.C. Sanders, P.M.P. Peeters, N.L. Reynaert. Maastricht, The Netherlands
P1.8 Epigenetic Analysis of Airway Epithelium: Prenatal Programming by Maternal Smoking?
KF Meyer, J Cao, MV Zwier, J Song, M Reinders-Luinge, W Kooistra, W Timens, P Nguyen, K Haley,
T Plösch, L Kobzik, MN Hylkema. Groningen, The Netherlands, Boston, USA
P1.9 Azithromycin differentially regulates IL-13 induced periostin, CLCA1 and SERPINB2 expression in
human bronchial epithelial cells
T.C.J. Mertens, R.M. Verhoosel, P.S. Hiemstra, C. Taube. Leiden, The Netherlands
P1.10 Effects of TGF-β on microRNA expression in COPD and control lung fibroblasts
V. Rajendran, J.L. Kluiver, A. van den Berg, A. Spira, M. Lenburg, J. Campbell, D.S. Postma, W. Timens,
C.A. Brandsma. Groningen, The Netherlands, Boston, USA
P1.11 ADAM17 activity is increased by Cigarette Smoke treatment and CFTR deficiency in lung
epithelial cells
Marta Stolarczyk, Gimano D. Amatngalim, Guido Veit, Gergely L. Lukacs, Pieter S. Hiemstra, Bob J
Scholte. Rotterdam, Netherlands, Leiden, Netherlands; Montreal, Canada
P1.12 Chronic cigarette smoke (CS) exposure alters differentiation of primary bronchial epithelial cells,
cultured at the air-liquid interface (PBEC-ALI)
JA Schrumpf, JB Veldkamp, TCJ Mertens, EFA van 't Wout, MC Zarcone, GD Amatngalim, PS Hiemstra.
Leiden
P1.13 Glucocorticoid Receptor-dependent impairment of protein synthesis regulation in hypoxia
induced muscle atrophy
C.C. de Theije, A.M.W.J. Schols, W.H. Lamers, E.S. Kohler, R.C.J. Langen. Maastricht
P1.14 Hypoxia differentially regulates muscle oxidative fiber-type and metabolism in a HIF-1αdependent manner
Ilse G.M. Slot, Annemie M.W.J. Schols, Bettine A.H. Vosse, Marco C.J.M. Kelders, Harry R. Gosker.
Maastricht
P1.15 TNF-α-induced classical NF-κB activation stimulates skeletal muscle glycolytic metabolism
through a HIF-1α-dependent mechanism
Remels AHV, Gosker HR, Langen RCJ, Schols AMWJ. Maastricht
P1.16 Latrophilin 3 a new receptor which increased airway smooth muscle mass and contraction in
asthmatic airways
A. Faiz, C. Donovan, B.G. Oliver, A.J. Halayko, K. Detillieux, J.P.T. Ward, T. Lee, J.L. Black, J.E. Bourke,
B. McParland, J.K. Burgess
Glebe, NSW/AU, Sydney, NSW/AU, Melbourne, VIC/AU, Winnipeg, MB/CA, London/UK
Poster Session P2: Clinical Science
Chairs:
Bernt van den Blink, Rotterdam
Anne-Marie Dingemans, Maastricht
P2.1
Prevalence, two-year stability and predictive performance of multiple-trigger and episodic
viral wheeze in preschool children
Gerben ter Riet, Karina E. van Wonderen, Lonneke B. van der Mark, Ronald B. Geskus, Wim M.C. van
Aalderen, Patrick J.E. Bindels. Amsterdam, Rotterdam
3
P2.2
Decreased lung function precedes severe RSV infection and post-RSV wheeze in term infants
Kim Zomer-Kooijker, Cuno S.P.M. Uiterwaal, Anne C. van der Gugten, Berry Wilbrink, Louis J Bont,
Cornelis K. van der Ent. Utrecht, Bilthoven
P2.3
The identification of asthma phenotypes by categorical PCA: combinatorial analysis of clinical
parameters and dysfunctional blood eosinophils
Bart Hilvering, Susanne Vijverberg, L. Houben, Rene Schweizer, Jan-Willem Lammers, Leo Koenderman.
Utrecht, the Netherlands
P2.4 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
G.A. Westerhof, D.A. Korevaar, M. Amelink, S.B. de Nijs, J.C. de Groot, E.J. Weersink, A. ten Brinke,
P.M.M. Bossuyt, E.H.D. Bel. Amsterdam, Leeuwarden
P2.5
Clinical and histological comparison of smoking and non-smoking patients with severe asthma in
the U-BIOPRED cohort
P.P.W. Hekking, A.H. Wagener, E.H. Bel, P.J. Sterk, U-BIOPRED Study group. Amsterdam; U-BIOPRED study
group listed at
http://www.europeanlung.org/en/assets/microsites/ubiopred/files/ubiopred_study_groups.pdf
P2.6 Association of COPD and smoking status with bone density and vertebral fractures in male lung
cancer screening participants
Firdaus A Mohamed Hoesein, Werner U de Jong, Pim A de Jong, Rozemarijn Vliegenthart, Ivana Isgum,
Matthijs Oudkerk, Carlijn van der Aalst, Harry J de Koning, Jan-Willem J Lammers. Utrecht, Groningen,
Rotterdam, The Netherlands
P2.7 Sarcopenia in relation to physical functioning in COPD
Coby van de Bool, Erica Rutten, Emiel Wouters, Annemie Schols. Maastricht, Horn, the Netherlands.
P2.8
Associations between comorbid load and baseline characteristics in COPD patients with
comorbidities: preliminary results
Anke Lenferink, Prof. Dr. Job van der Palen, Prof. Peter Frith MD,4, Dr. Paul van der Valk MD, Dr. Tanja
Effing. Enschede, the Netherlands; Adelaide, Australia
P2.9 MUC5B promoter polymorphism and susceptibility to pulmonary fibrosis in a Dutch cohort
J.J. van der Vis, R. Snetselaar, J.C. Grutters, C.H.M. van Moorsel. Nieuwegein, Utrecht, The Netherlands
P2.10 Assessment and standardization of chest CT in the European Cystic Fibrosis Society - Clinical
Trial Network
W. Kuo, E. Salamon, K.M. Logie, E.C. van der Wiel, M.P.C. Kemner-van de Corput, M. van Straten,
H.A.W.M. Tiddens. Rotterdam, the Netherlands
P2.11 30 Seconds tidal breathing method with AeroEclipse II nebulizer versus Aerosol Provocation
System (APS) in methacholine challenge testing.
Ellen Ruberg, Irene Steenbruggen, Jan Willem van den Berg. Zwolle
P2.12 Single-breath diffusion: comparison between helium and methane as tracer gases in COPD and
healthy controls.
RO Salvador, E Dijkers, RP van Steenwijk, PJ Sterk. Amsterdam
P2.13 Perceived health related quality of life in COPD patients: the role of illness perceptions
Saskia Weldam, Jan-Willem Lammers, Monique Heijmans, Marieke Schuurmans. Utrecht
P2.14 Integrating the patient perspective in coverage decisions regarding pharmaceuticals - the
development of a questionnaire
F.A. van Jaarsveld, L. Naber, C.D.Dirksen, P. Bresser, G.J.Teunissen, M.S.Wijsenbeek. Amersfoort,
Maastricht, Amsterdam, Rotterdam, the Netherlands
P2.15 WHAT ARE THE OPINIONS, EMOTIONS AND NEEDS OF ASTHMA AND COPD PATIENTS TOWARDS A
PATIENT WEB PORTAL: RESULTS FROM A FOCUSGROUP STUDY
4
E. I. Metting, T. Schrage, R. A. Riemersma, J. W. Kocks, R. Sanderman, T. van der Molen. Groningen
P2.16 LifeLines: a unique data and sample resource for research in pulmonology
S. Scholtens, J.M. Vonk, A. Dotinga, H.M. Boezen, D.S. Postma, R.P. Stolk. Groningen, the Netherlands
Poster presentations Thursday April 24, 14:30-15:30
Poster Session P3: Basic Science
Chairs:
Annemie Schols, Maastricht
Stan de Kleijn, Leiden
P3.1
Chronic exposure to HDM results in persistent neutrophilia and airway remodeling in mice
Heleen Vroman, Ingrid M. Bergen, Menno van Nimwegen, Jennifer A.C. van Hulst, Rudi W. Hendriks, Bernt
van den Blink, Mirjam Kool. Rotterdam, the Netherlands
P3.2
Lymph Node-Derived T Lymphocytes Display A Highly Activated And Proliferative State In
Pulmonary Sarcoidosis
C.E. Broos, M. van Nimwegen, J.C.C.M. in 't Veen, L.M. van den Toorn, M.S. Wijsenbeek, K.A.T. Boomars,
J.T. Annema, H.C. Hoogsteden, R.W. Hendriks, M.Kool, B.van den Blink. Rotterdam; Amsterdam
P3.3
Schistosome-induced pulmonary B cells protect against allergic airway inflammation and show a
reduced capacity to drive Th2 cytokine responses
L.E.P.M. van der Vlugt, Katja Obieglo, Simone Haeberlein, Arifa Ozir-Fazalalikhan, J. Sjef Verbeek, Maria
Yazdanbakhsh, Hermelijn H. Smits. Leiden, The Netherlands
P3.4 Airway epithelial basal cell expression of the antimicrobial peptide RNase 7: a second line of
defense induced upon epithelial injury
Gimano D. Amatngalim, Yolanda van Wijck, Yvonne de Mooij-Eijk, Renate M. Verhoosel, Pieter S. Hiemstra
Leiden, the Netherlands
P3.5 A direct anti-viral role for eosinophils?
Suzanne M. Bal, Yanaika S. Sabogal Piñeros, Lara Ravanetti, Annemiek Dijkhuis, Rene Lutter. Amsterdam
P3.6 Farm dust exposure alters macrophage phenotype and morphology in vitro: protective role in
the hygiene hypothesis?
T Borg, P Robbe, C Draijer, W Timens, A Spierenburg, I Wouters, B Melgert, M Hylkema. Groningen,
Utrecht, The Netherlands
P3.7 The Damage Associated Molecular Pattern (DAMP) release signature relates to susceptibility to
develop airway neutrophilia upon cigarette smoke exposure
Simon D. Pouwels, Irene H. Heijink, Lisette E. den Boef, Marike H. Boezen, Antoon J.M. van Oosterhout,
Martijn C. Nawijn. Groningen, The Netherlands
P3.8 Ratio of intratumoral macrophage phenotypes predicts local tumor outgrowth in malignant
pleural mesothelioma patients
L.A. Lievense, R. Cornelissen, J.L. Robertus, H.C. Hoogsteden, J.P.J.J. Hegmans, J.G.J.V. Aerts.
Rotterdam
P3.9 Classification of pulmonary neuro-endocrine tumours: too diverse for the clinician!
J.L. Derks, E.J. Speel, M. Béndek, A-M.C. Dingemans. Maastricht
P3.10 Treatment-induced immunological alterations in peripheral blood of stage IV non-small cell lung
cancer patients
Pauline de Goeje, Marlies Heuvers, Koen Bezemer, Cynthia Waasdorp, Joost Hegmans and Joachim Aerts.
Rotterdam
5
P3.11 Effect of chemotherapy and radiotherapy on function and composition of the immune system in
NSCLC
Mink Schinkelshoek, Mehrdad Talebian Yazdi, Nikki Loof, Marij Welters, Sjoerd van der Burg. Leiden
P3.12 Vitamin D3 is effective as an adjuvant for subcutaneous immunotherapy in a grass pollen-driven
mouse model of asthma
L. Hesse, M.C. Nawijn, A.H. Petersen, J.N.G. Oude-Elberink, J. Brimnes, A.J.M. van Oosterhout.
Groningen, The Netherlands; Hørsholm, Denmark.
P3.13 VX-809 and VX-770 treatment in rectal CF organoids expressing class I-V CFTR mutations
J.F. Dekkers, E. Kruisselbrink, A.M. Vonk, H.R. de Jonge, H.M. Janssens, I. Bronsveld, K.M. de Winter, C.K.
van der Ent, J.M. Beekman. Utrecht, Rotterdam, the Netherlands
P3.14 PDE3 inhibition by oral enoximone suppress allergic airway inflammation in a house dust mite
asthma model. New asthma treatment opportunity for an old drugs
Alex KleinJan, Menno van Nimwegen, Jan Beute, Rudi Hendriks. Rotterdam, Lelystad, Dronten, Emmeloord
P3.15 Enoximone in severe asthma
Jan Beute, Alex KleinJan. Lelystad, Rotterdam
P3.16 Quadriceps muscle fibre type shift is more pronounced in sarcopenic patients with COPD
Coby van de Bool, Harry Gosker, Bram van den Borst, Celine op den Kamp, Ilse Slot, Annemie Schols
Maastricht, the Netherlands.
P3.17 Preserved muscle oxidative metabolic phenotype in clinical cancer cachexia
H.R. Gosker, C.M. Op den Kamp, S. Lagarde, D.Y. Tan, F.J. Snepvangers, A.C. Dingemans, R.C. Langen,
A.M. Schols. Maastricht, the Netherlands
Poster Session P4: Clinical Science
Chairs:
Yvonne Heijdra, Nijmegen
Peter Merkus, Nijmegen
P4.1
The relation between hyperinflation and daily activity in COPD patients
Steven Dijkhuis, Marjolein Brusse-Keizer, Paul van der Valk, Monique Tabak, Frans de Jongh. Enschede
P4.2
Effectiveness of self-treatment of exacerbations in COPD patients: two-year follow-up of the
COPE-II study
Marlies Zwerink, Huib A.M. Kerstjens, Job van der Palen, Paul van der Valk, Marjolein Brusse-Keizer,
Gerhard Zielhuis, Tanja Effing. Enschede, Groningen, Nijmegen, the Netherlands; Daw Park, South
Australia, Australia; Adelaide, South Australia, Australia
P4.3
A community-based exercise programme in COPD self-management: two-year follow-up of the
COPE-II study
Marlies Zwerink, Job van der Palen, Huib A.M. Kerstjens, Paul van der Valk, Marjolein Brusse-Keizer,
Gerhard Zielhuis, Tanja Effing. Enschede, Groningen, Nijmegen, Daw Park, South Australia, Australia;
Adelaide, South Australia, Australia
P4.4 Patiëntenparticipatie bij de ontwikkeling van een individueel zorpglan voor mensen met astma
de Lange-Tichelaar, T., Pittens, C.A.C.M., Zweekhorst, M., Broerse, J.E.W.. Amsterdam
P4.5 How to assess COPD health status in secondary care clinical practice; preliminary results from a
Dutch Delphi procedure
EFMM van den Akker, JCCM in 't Veen, NH Chavannes, MP Rutten-van Mölken, AJ van ’t Hul. Rotterdam,
Nijmegen, Leiden
P4.6 The prevalence of adult severe refractory asthma in the Netherlands
P.P.W. Hekking, R.R.L. Wener, M.L. Bouvy, M. Amelink, E.H. Bel. Amsterdam
6
P4.7 Unbiased clustering of children with asthma or pre-school wheeze using the U-BIOPRED electronic
nose platform.
P. Brinkman, S. Hashimoto, prof. W.M. van Aalderen, prof. P.J. Sterk, U-BIOPRED study group.
Amsterdam; U-BIOPRED study group listed at
http://www.europeanlung.org/en/assets/microsites/ubiopred/files/ubiopred_study_groups.pdf
P4.8 Identification of atopy amongst wheezy infants via electronic nose
M. P. van der Schee, S. Hashimoto, M. van den Ouweland, N. Adriaens, A. C. Schuurman, A. B.
Sprikkelman, E. G. Haarman, W. M. C. van Aalderen, P. J. Sterk, EUROPA study group. Amsterdam
P4.9 Determinants of quality of life in children with asthma
Kim Zomer-Kooijker, Cuno S.P.M. Uiterwaal, Anke-Hilse Maitland-vd Zee, Walter A.F Balemans, Bart E. van
Ewijk, Maartje F. van Velzen, Cornelis K. van der Ent. Utrecht, Nieuwegein, Blaricum, Amersfoort
P4.10 The interrupter resistance measured with 2 systems; a comparison between the Whistler lfmi
and the MicroRint device.
Joyce Tersmette, Rolien Bekkema. Utrecht
P4.11 Comparison of new and old DLCO equipment in a pulmonary function laboratory
Leidy Lammers, Irene Steenbruggen, Mariët van Doornik, Hans Grotjohan. Zwolle
P4.12 Digital tool for support of medical indoor environment counselling
F.E. van Boven on behalf of Dutch working group on allergen avoidance, Verpleegkundigen & Verzorgenden
Nederland
P4.13 Patient specific evaluation of regional antibiotic concentration levels in a cohort of patients with
cystic fibrosis
A.C.Bos, C. van Holsbeke, J.W. de Backer, M. van Westreenen, W.G. Vos, H.M. Janssens, H.A.W.M. Tiddens
Rotterdam, the Netherlands; Kontich, Belgium
P4.14 Health Impact Assessment; Wat is een effectieve bestrijding van longziekten door werk?
Birgit van Duuren, Ruud Boessen, Anjoeka Pronk. Zeist
7
First or corresponding author index
Last Name
Akker
Amatngalim
Bal
Bekkema
Beute
Bezemer
Bezemer
Bool
Bool
Boorsma
Borg
Bos
Boven
Brinkman
Broos
Budding
Crommelin
Dekkers
Derks
Dijkhuis
Draijer
Duuren
Faiz
Goeje
Gopal
Gosker
Hekking
Hekking
Hesse
Heukels
Hilvering
Jaarsveld
Khedoe
Kistemaker
Kleer
KleinJan
Kuo
Lange-Tichelaar
Lenferink
Lievense
Lievense
Mertens
Metting
Meyer
Mohamed Hoesein
Ommen
Osei
Pouwels
Rajendran
Presentation number
P4.5
P3.4
P3.5
P4.10
P3.15
O1.6
P1.1
P2.7
P3.16
O1.4
P3.6
P4.13
P4.12
P4.7
P3.2
O2.3
P1.4
P3.13
P3.9
P4.1
O2.4
P4.14
P1.16
P3.10
O2.1
P3.17
P4.6
P2.5
P3.12
O2.5
P2.3
P2.14
P1.5
O1.5
O1.2
P3.14
P2.10
P4.4
P2.8
O2.6
P3.8
P1.9
P2.15
P1.8
P2.6
O1.1
P1.2
P3.7
P1.10
8
Remels
Riet
Ruberg
Salvador-Ong
Sanders
Schinkelshoek
Scholtens
Schrumpf
Slot
Sneeboer
Snetselaar
Steenbruggen
Stolarczyk
Theye
van der Schee
Vernooy
Vis
Vlugt
Vroman
Weldam
Westerhof
Wijck
Zomer-Kooijker
Zomer-Kooijker
Zwerink
Zwerink
P1.15
P2.1
P2.11
P2.12
P1.7
P3.11
P2.16
P1.12
P1.14
O2.2
P1.3
P4.11
P1.11
P1.13
P4.8
P1.6
P2.9
P3.3
P3.1
P2.13
P2.4
O1.3
P2.2
P4.9
P4.2
P4.3
9

Download Report